Cancer Treatment News and Research

RSS

Zebrafish model reveals how BCG vaccine triggers immune response in bladder cancer

Using zebrafish "Avatars", an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López – a former PhD student at the lab now working at the Universidad de las Américas in Quito, Ecuador – and colleagues studied the initial steps of the Bacillus Calmette-Guérin (BCG) vaccine's action on bladder cancer cells.

8 Aug 2024

Review of fasting-mimicking diets in cancer treatment

Researchers present the role of cyclic fasting and fasting-mimicking diets (FMD) in cancer therapy.

8 Aug 2024

USC Norris to open state-of-the-art cancer center in Newport Beach with advanced radiation therapy

USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, will open a Newport Beach location offering the latest advancements in radiation therapy and diagnostic imaging.

7 Aug 2024

Discovery of Tr1 cells as a barrier to cancer immunotherapy offers new hope for treatment

Immunobiologists Robert Schreiber, PhD, (left) and Hussein Sultan, PhD, of Washington University School of Medicine in St. Louis, found that a subset of immune cells that normally puts the brakes on the immune system to prevent it from attacking the body's healthy cells inadvertently also dampens cancer immunotherapy.

7 Aug 2024

Small-town patients face big hurdles as rural hospitals cut cancer care

The night before her chemotherapy, Herlinda Sanchez sets out her clothes and checks that she has everything she needs: a blanket, medications, an iPad and chargers, a small Bible and rosary, fuzzy socks, and snacks for the road.

7 Aug 2024

METRNL protein identified as key player in cancer progression

A protein called Meteorin-like (METRNL) in the tumor microenvironment saps energy from T cells, thereby severely limiting their ability to fight cancer, according to new research directed by investigators at the Johns Hopkins University School of Medicine and the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy. Finding ways to block the effects of METRNL signaling on tumor-infiltrating T cells may allow these immune cells to regain the energy necessary to eliminate tumors.

7 Aug 2024

Researchers uncover immune system barrier to cancer treatment

By recruiting the immune system to combat tumor cells, immunotherapy has improved survival rates, offering hope to millions of cancer patients. However, only about one in five people responds favorably to these treatments.

7 Aug 2024

AI-powered tool enhances handheld ultrasound for heart imaging

A handheld, portable ultrasound probe that's the size of a fat window squeegee can peer inside your heart - but this amazing piece of technology still requires highly trained medical personnel to operate it.

6 Aug 2024

Image-guided cancer treatment using biocompatible copper-based nanomaterials

Announcing a new article publication for BIO Integration journal. Cancer is a significant disease that poses a major threat to human health.

6 Aug 2024

Harnessing oncolytic viruses for cancer immunotherapy to improve treatment outcomes

Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a unique potential to selectively target malignant cells while sparing normal tissues.

6 Aug 2024

Cancer screening costs exceed $40 billion annually in the United States

A modeling study estimates cancer screening costs in the United States exceed $40 billion annually, highlighting the need for policy prioritization to enhance equitable access. The study emphasizes that recommended screenings significantly reduce cancer-specific mortality and can be cost-effective.

5 Aug 2024

Quality-of-life measurements are essential in cancer care, study says

As novel cancer treatments continually emerge, it is essential to collect data on patients' quality of life along with how the treatment is working to extend survival.

5 Aug 2024

Racial bias found in cancer treatment approvals

Prior authorization - the process by which a health insurance company denies or approves coverage for a health care service before the service is performed - became standard practice beginning with Medicare and Medicaid legislation in the 1960s.

2 Aug 2024

Uncovering hidden drug benefits through protein mapping

Fewer side effects, improved chances of healing: the goal of precision medicine is to provide patients with the most individualized treatment possible. This requires a precise understanding of what is happening at the cellular level. For the first time, researchers at the Technical University of Munich (TUM) have now succeeded in mapping the interactions of 144 active substances with around 8,000 proteins. The results could help to identify previously unknown potential benefits of existing drugs.

2 Aug 2024

Applying antifragility theory to cancer could revolutionize treatment methods

Researchers constantly seek innovative approaches to tackle cancer. One concept gaining traction is antifragility, a property where systems not only withstand stress but improve because of it.

1 Aug 2024

The complex relationship between diet nutrition and cancer

The existing knowledge on the beneficial and detrimental effects of dietary patterns and nutritional supplements on cancer risk.

1 Aug 2024

Masking policies prevalent in top cancer centers amid winter COVID wave

Nearly half of the nation's National Cancer Institute (NCI)-designated cancer centers required universal masking in key clinical areas during the winter 2023-2024 COVID-19 surge, according to a study by Tulane University researchers.

1 Aug 2024

UC San Diego develops AI tool for rapid, low-cost detection of genomic alterations in cancer

A new generation of artificial intelligence (AI) tools designed to allow rapid, low-cost detection of clinically actionable genomic alterations directly from tumor biopsy slides has been developed by a team led by engineers and medical researchers at University of California San Diego.

1 Aug 2024

Breakthrough X-ray-sensitizers could revolutionize radiotherapy for cancer patients

Researchers at Xiamen University have made a significant advancement in cancer treatment by developing a novel class of X-ray-sensitizers (XSs) that could revolutionize radiotherapy.

31 Jul 2024

Study links tissue-resident memory T cells to improved lung cancer outcomes

An extensive analytical study performed at the Terasaki Institute and published in Frontiers in Immunology highlights the crucial role of tissue-resident memory T cells and how they influence the immune environment of patients with non-small cell lung cancer and their overall prognosis.

30 Jul 2024